Literature DB >> 2218550

Panoramic nailfold capillaroscopy: a new reading method and normal range.

L E Andrade1, A Gabriel Júnior, R L Assad, A J Ferrari, E Atra.   

Abstract

Current interpretation of nailfold capillaroscopy is largely based on qualitative and subjective parameters. These parameters make the accurate assessment of the extent of the nailfold microangiopathy difficult. The authors present a comprehensive method in which several quantitative or semiquantitative parameters are used to assess the main microangiopathic features, such as microhemorrhage, plexus visibility, devascularization, and morphologic anomalies of the end row loops. The method is checked for reproducibility and applied to a sample of 800 healthy people to establish the normal range. The influences of extrinsic variables, such as gender, ethnicity, age, and local nailfold conditions are also included.

Entities:  

Mesh:

Year:  1990        PMID: 2218550     DOI: 10.1016/0049-0172(90)90091-s

Source DB:  PubMed          Journal:  Semin Arthritis Rheum        ISSN: 0049-0172            Impact factor:   5.532


  28 in total

1.  Nailfold capillary microscopy in healthy children and in childhood rheumatic diseases: a prospective single blind observational study.

Authors:  P Dolezalova; S P Young; P A Bacon; T R Southwood
Journal:  Ann Rheum Dis       Date:  2003-05       Impact factor: 19.103

2.  [Capillaroscopy. Procedure and nomenclature].

Authors:  O Sander; C Sunderkötter; I Kötter; I Wagner; M Becker; I Herrgott; A Schwarting; B Ostendorf; C Iking-Konert; E Genth
Journal:  Z Rheumatol       Date:  2010-05       Impact factor: 1.372

3.  The effect of cigar smoking on the lingual microcirculation.

Authors:  Giuseppe A Scardina
Journal:  Odontology       Date:  2005-09       Impact factor: 2.634

4.  Quantitative nailfold capillaroscopy findings in a population with connective tissue disease and in normal healthy controls.

Authors:  Y Kabasakal; D M Elvins; E F Ring; N J McHugh
Journal:  Ann Rheum Dis       Date:  1996-08       Impact factor: 19.103

5.  Predictive value of nailfold capillaroscopy in the diagnosis of connective tissue diseases.

Authors:  D Blockmans; G Beyens; R Verhaeghe
Journal:  Clin Rheumatol       Date:  1996-03       Impact factor: 2.980

6.  Pan-American League of Associations for Rheumatology (PANLAR) capillaroscopy study group consensus for the format and content of the report in capillaroscopy in rheumatology.

Authors:  Chiara Bertolazzi; Angélica Vargas Guerrero; Tatiana Sofía Rodríguez-Reyna; Hugo Sandoval; Everardo Álvarez-Hernández; Marcelo José Audisio; Eduardo Cabello; Paola Coral-Alvarado; Ericka Díaz; Virginia Duringan; Karinna Espejo; Selma Gallegos; Gabriela Hernández-Molina; Blanca Herrera; Cristiane Kayser; María Eugenia Lara; Genessis Maldonado; Marta N Mamani; Alejandro Nitsche; Carlos Ríos-Acosta; Félix Enrique-Romanini; María Sormani de Fonseca; Verónica Silva Vilela; Miguel Angel Villarreal-Alarcón; Marwin Gutiérrez
Journal:  Clin Rheumatol       Date:  2019-06-08       Impact factor: 2.980

7.  Nailfold capillaroscopic changes in dermatomyositis and polymyositis.

Authors:  A Manfredi; M Sebastiani; G Cassone; N Pipitone; D Giuggioli; M Colaci; C Salvarani; C Ferri
Journal:  Clin Rheumatol       Date:  2014-10-17       Impact factor: 2.980

8.  Capillary loss on nailfold capillary microscopy is associated with mortality in systemic sclerosis.

Authors:  Thais Rohde Pavan; Markus Bredemeier; Vanessa Hax; Karina Gatz Capobianco; Rafael da Silva Mendonça Chakr; Ricardo Machado Xavier
Journal:  Clin Rheumatol       Date:  2017-10-10       Impact factor: 2.980

Review 9.  [Capillaroscopy and rheumatic diseases: state of the art].

Authors:  M Cutolo; A Sulli; M E Secchi; C Pizzorni
Journal:  Z Rheumatol       Date:  2006-07       Impact factor: 1.372

10.  Raynaud's phenomenon in undifferentiated connective tissue disease (UCTD).

Authors:  Rossella De Angelis; Angela Cerioni; Patrizia Del Medico; Patrizia Blasetti
Journal:  Clin Rheumatol       Date:  2004-09-04       Impact factor: 2.980

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.